Bioreactor for the manufacture of tissue engineered blood...

Surgery – Blood vessel or graft preparation

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07744526

ABSTRACT:
The invention relates to bioreactors having an enclosed chamber, a sheet growth module, a rollable mandrel, and a clamp for holding the sheet to the mandrel for rolling for the manufacture of a tissue engineered blood vessel (TEBV). The TEBV is made from a cultured fibroblast sheet rolled into a multilayer vessel which has sufficient burst strength to withstand physiological blood pressure without the inclusion of smooth muscle cells or synthetic scaffolding.

REFERENCES:
patent: 4441215 (1984-04-01), Kaster
patent: 4546500 (1985-10-01), Bell
patent: 4963489 (1990-10-01), Naughton et al.
patent: 5429927 (1995-07-01), Afseth et al.
patent: 5443950 (1995-08-01), Naughton et al.
patent: 5618718 (1997-04-01), Auger et al.
patent: 5628786 (1997-05-01), Banas et al.
patent: 5785964 (1998-07-01), Naughton et al.
patent: 5792603 (1998-08-01), Dunkelman et al.
patent: 5863531 (1999-01-01), Naughton et al.
patent: 5865723 (1999-02-01), Love
patent: 5902228 (1999-05-01), Schulsinger et al.
patent: 5962325 (1999-10-01), Naughton et al.
patent: 6010573 (2000-01-01), Bowlin et al.
patent: 6077217 (2000-06-01), Love et al.
patent: 6121042 (2000-09-01), Peterson et al.
patent: 6127448 (2000-10-01), Domb et al.
patent: 6140127 (2000-10-01), Sprague et al.
patent: 6206914 (2001-03-01), Soykan et al.
patent: 6455311 (2002-09-01), Vacanti
patent: 6468300 (2002-10-01), Freidberg
patent: 6479252 (2002-11-01), Barbera-Guillem et al.
patent: 6503273 (2003-01-01), McAllister et al.
patent: 7112218 (2006-09-01), McAllister et al.
patent: 7504258 (2009-03-01), McAllister et al.
patent: 2003/0199967 (2003-10-01), Hartley et al.
patent: 2004/0193254 (2004-09-01), Greenberg et al.
patent: 2007/0178588 (2007-08-01), McAllister et al.
patent: WO 99/59506 (1999-11-01), None
Scott, N.A. et al., “Seeding of intracoronary stents with immortalized human microvascular endothelial cells”,American Heart Journal, vol. 129, No. 5 (1995), pp. 860-866.
Eming, S.A. et al., “Enhanced Function of Cultured Epithelium by Genetic Modification: Cell-Based Synthesis and Delivery of Growth Factors”,Biotechnology and Bioengineering, vol. 52 (1996), pp. 15-23.
Cytograft Tissue Engineering, Inc., Supplemental Search Report of the European Patent Application No. 00991034.0 dated Jan. 31, 2008, 5 pages.
Cytograft Tissue Engineering, Inc., Examination Report of the European Patent Application No. 00991034.0 dated May 13, 2008, 5 pages.
“A Completely Biological Tissue-Engineered Human Blood Vessel,” L'Heureux, N., et al., FASEB Journal, 12: 47-56, 1998.
U.S. Appl. No. 12/406,007, filed Mar. 17, 2009, McAllister et al.
U.S. Appl. No. 12/515,397, filed May 18, 2009, L'Heureux et al.
U.S. Appl. No. 12/485,898, filed Jun. 16, 2009, McAllister et al.
Carnevale, K. et al., “Biological Coating for Arterial Stents: The Next Evolutionary Change in Stents”, J. Endovasc Ther, (2006), 13:164-174.
Ishii, S. et al., “Optimal Covering Material for Stent-Grafts Placed in the Portal Vein in a Canine Model”, Cardiovasc Intervent Radiol, (2005), 28:624-631.
Shirota, T. et al., “Intralumenal Tissue-Engineered Therapeutic Stent Using Endothelial Progenitor Cell-Inoculated Hybrid Tissue and in Vitro Performance”, Tissue Engineering, 9(3):473-489 (2003).
Yavuz, K. et al., “Comparison of the Endothelialization of Small Intestinal Submucosa, Dacron, and Expanded Polytetrafluoroethylene Suspended in the Thoracoabdominal Aorta in Sheep”, J Vasc Interv Radiol, 17:873-882 (2006).
Toyota, N. et al., “Comparison of Small Intestinal Submucosa-covered and Noncovered Nitinol Stents in Sheep Iliac Arteries: A Pilot Study”, J Vasc Interv Radiol, 13:489-498 (2002).
Park, J.W. et al., “Small Intestinal Submucosa Covered Expandable Z Stents for Treatment of Tracheal Injury: An Experimental Pilot Study in Swine”, JVIR, 11:1325-1330 (2000).
Fujiwara, N. H. et al., “Type 1 Collagen as an Endovascular Stent-Graft Material for Small-diameter Vessels: A biocompatibility Study”, J Vasc Intery Radiol, 16:1229-1236 (2005).
Cytograft Tissue Engineering, Inc., International Search Report and the Written Opinion for PCT Application No. PCT/US2009/047576 dated Aug. 19, 2009, 13 pages.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bioreactor for the manufacture of tissue engineered blood... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioreactor for the manufacture of tissue engineered blood..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioreactor for the manufacture of tissue engineered blood... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4247091

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.